Formulation of stimuli-responsive gels containing silver complex with nicotinamide
, , , , und
31. Aug. 2025
Über diesen Artikel
Artikel-Kategorie: Research paper
Online veröffentlicht: 31. Aug. 2025
Eingereicht: 09. Juni 2025
Akzeptiert: 08. Juli 2025
DOI: https://doi.org/10.2478/afpuc-2025-0007
Schlüsselwörter
© 2025 Wolaschka Tomáš et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.
Figure 2.
Figure 3.
Figure 4.
Appearance and injectability of sols and gels_
| PMSA 0.2 | +++ | − | + | ++ | ++ | +++ |
| PMSA 0.3 | +++ | − | + | + | ++ | +++ |
| PMSA 0.4 | +++ | +++ | + | + | + | +++ |
| PMSA 0.5 | +++ | +++ | + | + | + | +++ |
| PMSA 0.6 | +++ | +++ | + | + | + | ++ |
| PMSA 0.7 | ++ | ++ | + | + | + | ++ |
| PMSA 0.8 | ++ | ++ | + | + | + | ++ |
| PSA | +++ | − | − | − | + | + |
| PMSA | +++ | − | − | − | + | + |
| MSA | ++ | − | − | + | + | + |
| SA | ++ | − | − | + | + | + |
| PMSA AgNam | + | − | − | − | + | + |
pH and critical sol–gel transition temperature of the formulations_
| PMSA 0.2 | 6.78 ± 0.00 | - |
| PMSA 0.3 | 6.72 ± 0.00 | - |
| PMSA 0.4 | 6.70 ± 0.00 | 34.10 ± 0.28 |
| PMSA 0.5 | 6.68 ± 0.01 | 33.36 ± 0.13 |
| PMSA 0.6 | 6.64 ± 0.00 | 32.66 ± 0.17 |
| PMSA 0.7 | 6.61 ± 0.00 | 33.60 ± 0.08 |
| PMSA 0.8 | 6.60 ± 0.01 | 31.50 ± 0.36 |
| PSA | 6.16 ± 0.02 | - |
| PMSA | 6.26 ± 0.00 | - |
| MSA | 5.84 ± 0.00 | - |
| SA | 5.75 ± 0.01 | - |
| PMSA AgNAM | 5.61± 0.02 | - |
Composition of formulations_
| PMSA 0.2 | 15.00 | 0.25 | 0.20 | - |
| PMSA 0.3 | 15.00 | 0.25 | 0.30 | - |
| PMSA 0.4 | 15.00 | 0.25 | 0.40 | - |
| PMSA 0.5 | 15.00 | 0.25 | 0.50 | - |
| PMSA 0.6 | 15.00 | 0.25 | 0.60 | - |
| PMSA 0.7 | 15.00 | 0.25 | 0.70 | - |
| PMSA 0.8 | 15.00 | 0.25 | 0.80 | - |
| PSA | 15.00 | - | 4.00 | - |
| PMSA | 15.00 | 0.25 | 4.00 | - |
| MSA | - | 0.25 | 4.00 | - |
| SA | - | - | 4.00 | - |
| PMSA AgNam | 15.00 | 0.25 | 4.00 | 1.00 |